Navigation Links
AAIPharma Services Corp. Names Patrick Walsh Chief Executive Officer

WILMINGTON, N.C., Sept. 14 /PRNewswire/ -- AAIPharma Services Corp., a leading provider of pharmaceutical product development services for more than 30 years, announced today that it has appointed Patrick D. Walsh to chief executive officer.  Water Street, a strategic private equity firm focused exclusively on health care that acquired AAIPharma Services in a divestiture transaction from its parent company in 2009, was instrumental in recruiting Mr. Walsh to the position.  

Mr. Walsh, who has nearly 30 years of pharmaceutical manufacturing experience, will focus on advancing AAIPharma's next phase of strategic growth following its establishment as a standalone company.  Mr. Walsh has served in executive roles at multiple pharmaceutical companies, including as president and CEO of Kadmus Pharmaceuticals, Inc., and president and COO of Gensia Sicor.  He also served as CEO of a specialty diagnostic company, and led the U.S. and international business groups for Fujisawa USA.  Most recently, Mr. Walsh founded a management consulting firm that assisted companies with achieving key corporate objectives in the pharmaceutical, contract manufacturing and biotechnology industries.

"Pat has an impressive record of consistently leading pharmaceutical businesses to achieve high levels of growth over the course of his career.  He is the ideal executive to advance AAIPharma Services forward, as we focus on pursuing growth opportunities through a combination of organic initiatives and strategic acquisitions.  Pat's core skills of business development, relationship-building, and sales and marketing will contribute significantly to AAIPharma and our goal of building it into the leading provider of pharmaceutical development services," said Pete Strothman, a principal with Water Street and a member of AAIPharma Services' board of directors.

In addition to his executive experience, Mr. Walsh has served on the boards of directors of more than 10 companies in the pharmaceutical and contract manufacturing industries.  L. Lee Karras, who led AAIPharma Services through its transition to an independent company, will continue in his role as president and will also assume the responsibility of chief operating officer.  He will work closely with Mr. Walsh to implement the company's strategic growth plan.

"AAIPharma Services is highly regarded for its expertise and ability to collaborate with its customers to consistently deliver high-quality results.  It is this unique value proposition, which the company has honed over the past 30 years that will serve as the foundation for our future," said Mr. Walsh.  "I look forward to working with the team to determine how we can best build on the company's core capabilities to provide even greater value to our customers and expand our presence on a much greater scale globally."

About AAIPharma Services Corporation

AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies throughout North America.  It is headquartered in Wilmington, North Carolina.  For more information on the company, visit

About Water Street Healthcare Partners

Water Street Healthcare Partners is a strategic private equity firm focused exclusively on health care.  The firm has a strong record of building market-leading companies across key growth sectors in health care.  It has partnered with some of the world's leading health care companies on its investments including: Johnson & Johnson, Medtronic and Smith & Nephew.  Water Street's team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses.  The firm is headquartered in Chicago.  For more information about Water Street, visit

SOURCE AAIPharma Services Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. West Pharmaceutical Services, Inc. Appoints New Director
2. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
5. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
6. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
7. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
8. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
9. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
10. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
11. Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials
Post Your Comments:
(Date:12/1/2015)... Russia has always been a ... new drugs registered in Europe in 2015 were ... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... Russia has always been a country of choice for global ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... 1, 2015  The migration to value-based care ... care plans that help patients stay healthy and ... be digitally enabled, incorporate care guidelines and be ... They will also allow all stakeholders to collaborate ... is optimal. That is the vision, however, research ...
Breaking Medicine Technology:
(Date:12/1/2015)... (PRWEB) , ... December 02, 2015 , ... Ruth Pearson ... brutal lupus flare-up. Unable to walk without assistance and quickly losing hope of recovering ... then a miracle happened. , Pearson was attending a women’s retreat when she experienced ...
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition ... funds for Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday ... from patients including their ability to work and be productive, to do simple daily ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Royal River Natural ... new study that found post-menopausal women who took the nutritional supplement creatine, along with ... who trained but did not take creatine. , The report is part of the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... leadless pacemakers in the U.S. and is the only hospital in the region ... largest clinical data presentation of transcatheter pacing patients were revealed recently at a ...
(Date:12/1/2015)... ... 01, 2015 , ... December 1, 2015 -- InstantLabs is ... growing product line of food safety and seafood fraud prevention tools. , The ... allow InstantLabs to offer fast, reliable species identification for the four most popular ...
Breaking Medicine News(10 mins):